Condition: Multiple Sclerosis · Cognitive Impairment · Sponsor: Clinical Academic Center (2CA-Braga)
This is a phase II/exploratory clinical trial with a single-center, open-label design to evaluate the effect of modafinil on cognitive deficits in adult patients with multiple sclerosis and identify predictors of response using functional Magnetic Resonance Imaging (fMRI).
This description comes directly from the study's public registry record.
Mónica Gonçalves · +351 253 027 249 · 2ca@ccabraga.org
Rosana Magalhães · +351 253 027 249 · cro@ccabraga.org
Always discuss trial participation with your own doctor first.
| Clinical Academic Center - Braga (2CA-Braga) | Braga, Portugal | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06592352